Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Doesn't look like Koos got the 60 mill from MEV. Now he has has to pay back the 4 million to Klaas. Hope he's got it or else he might be losing his knee caps. Probably what all the dilution is about.
According to Mass Equity Ventures web sight, they only loan up to 10 million dollars. Do you think that it is wise to believe Koos' claim that he can get 60m?
The stock price hit an all time low today but what do I know. I'm sure it's just a great opportunity to buy :/
Or in your case should I say average down.
Yeah... a real Biopharm company would do if they had such a wonderful cure all is file a new drug application with the FDA. It's fake news, don't waste your money.
Yes it's dilution. They put a PR out so note holders can dump their convertible shares. It's been going on for a while now.People keep falling for it.
The terms of all of those derivatives were what you would expect from a loan shark. The chickens have come home to roost. When all of those pumpers were posting that no dilution was going on I had to laugh. They w
Google the address of the new corporate headquarters for BMSN and check the street view.
1204 Tangerine St
El Cajon, California
Pretty impressive. Is that trailer in the driveway where they store the data?
Yes in a couple of weeks a new PR will be out making a vague claim with no proof to support it. Something like, NR2F6 combined with CBD raises midichlorian counts off the charts! It will be HUGE NEWS!!
Being skeptical about anything that Koos does I read this in the 8-k:
(b) the MEV Transaction ( as such term is defined in the Klaas Agreement) results in an initial advance being received by Zander from Mass Equity Ventures LLC in excess of $12,000,000 US on or before December 1, 2019, then within three days from actual receipt by Zander of the initial advance by Mass Equity Ventures LLC , Zander shall:
I. Repay the Loan.
Yet on the MEV websight they post that they do not loan such a high amount:
"We are flexible on ownership percentage and other factors of investments. We are open to any deal size, but we typically invests between $100,000 and $5 million in a first check"
"WILL INVEST UP TO $10 MILLION OVER MULTIPLE ROUNDS"
But anything is possible I guess. FWIW
Loan sharks.
This is not a pharmaceutical company. They just sell supplements.
Read the new 10-Q. See the dilution?
The only boat being missed is the nice sailboat that shareholders bought for commodore Koos. Grubby common stock owners are not invited to go on a sail. LOL
It was ready to run a couple days ago. What happened?
For 10 years now Koos has been running this pharmaceutical scam without producing anything except a trail of disappointed investors. Still there are always more gullible people willing to throw money at him every time he puts out another PR. Simply amazing!
Just be sure to flip it just as fast as that person or you'll be caught holding the bag.
There is currently no short interest in RGBP and I doubt that you could find a broker that would allow you to short it.
Those convertible share are also discounted. The holder can convert and sell those shares any given day, regardless of share price, and make a profit so long as there are buyers. Right now there are buyers. You can go ahead and buy right now and hope that the share count doesn't go up but that's like playing poker and bluffing against someone with a royal flush and hoping he doesn't call you. Good luck.
There's over a billion unrestricted shares held by convertible note holders that can be dumped on the market, especially when the price pumps up like this. So no,you really don't know. Bunch of people that have been following this company for 5 whole days spouting off a lot of misinformation.
How would you actually know that. It hasn't been updated in months. They are not op to date with financials.
It's almost like there's a never ending supply of new shares being put up for sale.
Why GW pharma trade 166$/share on Nasdaq, what they have better than us?
1. up to date financials
2. They trade on NASDAQ not the Pink Sheets
3. The have FDA approved products on the market not just patent applications.
4. Their stock is covered by analysts from 13 major brokerages
5. Their products are represented in the US and 5 European countries.
I found all of this in 10 minutes. There is no comparison. RGBP is run out of an office suite in a strip mall.
It would roll over to RGBPP first before BMSN which it hasn't. RGBP is just being played by a few traders. They'll soon be gone after they've created a few new bag holders. The news was not anything new.
What's really crazy is that nobody except a handful of penny stock day traders are taking notice of this amazing news. You would think that big pharma would be all over this as well as the scientific community in general.
Don't big pharmaceutical companies have staff dedicated to finding opportunities just like this? How has RGBP flown under their radar for so many years? This is indeed an incredible ground floor bonanza!
I can't wait to see where this will be in about two weeks.
Unless the note holders unload a bunch of newly converted shares due to the run up of the price which is exactly what happened the last time. You really should familiarize yourself with how this operates.
Nobody knows how many unconverted shares are available to be added to the float because the financials are not up to date but my last count was about 1.6 billion. Not as thin as it appears.
It's the same rehashed PR that they have been putting out for over a year with a few details and embellishments. Even if they get a patent that's as far as it goes. Same with all their other patents.
No dilution? LOL that's a good one. 4 billion new shares were just authorized. This is just a Koos engineered P&D. He shouldn't even be putting out these promo PRs if he can't even keep the financials up to date. Some people may be making a quick buck here but more are going to get hurt when this run is over. I hope the SEC is keeping an eye on this.
More shares, That's awesome.
It often does as the price decreases.
Tuesday RGBP
and still no quarterly report.
They are one and the same. All are intertwined, RGBP, RGBPP, BMSN, Zander Therapeutics, KLP Therapeutics, etc. Big scam. But if you are looking for a cheep penny stock to P&D, go for it, good luck.
They may no longer have any funds left but with no recent financial reporting being made, who knows?
All you can do is wait until the shares get listed on an exchange so that they can be traded or Zander could be acquired by another company and you would then get either shares in that company or cash for your shares.
The NT 10-Q/A for Zander was filed on the same day as the one for RGBP. What I posted is true. If it's filed late it is delinquent. Everything that Koos does should be eyed with suspicion IMO. Millions of dollars have been lost with nothing to show for it.
Zander is delinquent in filing it's 10-Q just like Regen.
Apparently the plan combine CBD with NR2F6 has not panned out. This is why Landers was dispatched to Southeast Asia. The new plan now is to combine NR2F6 with ancient Asian remedies. Unfortunately Harry has been having trouble earning the trust of native traders and has not been able to procure any of the desired rhino horn or tiger penis as of yet. But stay tuned faithful investors. The next magical PR announcing the cure for everything is just around the corner, and all of your wildest dreams will come true.
Feel free to copy and paste this post to all the usual get rich quick threads. We're gonna be rich!
I don't think that RGBP has been doing any of this lately.
Well, we all got into this because we believed in what Koos was selling and we all have lost money investing in it. I still believe that HemaXellerate could have been a beneficial therapy and maybe NR2F6 can be developed but Koos clearly was not interested in going to clinical trials with anything in the pipeline. I'm interested in seeing the overdue 10-Q. I have a feeling that it is going to show that the convertible note well has run dry and Regen is probably on the brink of BK. Just a hunch.
I have no answer for that but the accounting can't be that complicated. Literally nothing happened last quarter other than the Landers thing.
This from OTC Markrts
Warning! This company has posted limited financial disclosure through the OTC Disclosure & News Service or is late in their filing obligations with the SEC.
The future looks... gray.